DiscoverStartupsBontiBonti Funding Rounds, Valuation & Investors
Bonti company logo
Bonti
Closed
Developing next generation neurotoxins for treating indications with strong unmet needs
View 0 jobs

Bonti Funding

$0
22 rounds
Bonti is active in the following markets / industries: pharmaceuticals and bio pharm. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on September 14, 2018.

Funding Rounds

ACQ
$195000000
AcquiredSep 2018$0 valuation
Press
Allergan To Acquire Bonti Adding New Neurotoxin Pr
A
$8900000
Series ASep 2015$0 valuation

Investors of Bonti

RBV Capital
VC Firm
Colt Ventures
VC Firm • Dallas
Avatar for Colt Ventures
City Hill Ventures
VC Firm • San Diego
Avatar for City Hill Ventures
Back to People
Onwards to Jobs